期刊文献+

载药微球联合BMP-2治疗兔慢性骨髓炎的实验研究 被引量:2

Experimental study on the drug loaded microspheres combined with BMP-2 in the treatment of chronic osteomyelitis in rabbits
下载PDF
导出
摘要 目的探讨载药纳米羟基磷灰石/壳聚糖(n-HA/CS)新型植入材料治疗慢性骨髓炎的可行性。方法将60只健康新西兰大白兔分为4组构建骨髓炎模型,按以下方法植入材料,A组:不做任何处理;B组:单纯n-HA/CS支架材料;C组:nHA/CS载万古霉素脂质体种植体;D组:n-HA/CS载万古霉素脂质体种植体与BMP-2。8周后通过细菌培养及组织病理学检测,评价其抗感染能力及修复骨缺损的能力。结果载药n-HA/CS人工植入材料能够释放高浓度的抗菌药物;植入载药n-HA/CS联合BMP-2可有效控制骨感染并促进骨组织的修复;治疗效果明显优于单纯载药n-HA/CS材料组及单纯n-HA/CS材料组。结论载药n-HA/CS联合BMP-2是治疗兔慢性骨髓炎的较为理想的植入材料。 Objective To investigate the anti‐infection and bone repair effects of cationic liposome‐encapsulatedvancomycin combined with the nano‐hydroxyapatite/chitosan(n‐HA/CS) composite scaffold in vivo .Methods Sixty 6‐month‐old New Zealand white rabbits ,weighing 2 .5 kg ,were selected to prepare chronic infectious tibia bone defect model by using Staphylococcus aureus . After 4 weeks ,60 survival rabbits were randomly divided into 4 groups(n=15) .After debridement ,defect was treated with nothing in group A ,with n‐HA/CS composite scaffold in group B ,with vancomycin and n‐HA/CS composite scaffold in group C ,and with cationic liposome‐encapsulated vancomycin and n‐HA/CS composite scaffold in group D .After 8 weeks of treatment ,general obser‐vation ,X‐ray ,HE staining .Results At 4 weeks after modeling ,60 rabbits were diagnosed as having osteomyelitis ,including perios‐teal new bone formation ,destruction of bone ,and soft tissue swelling .At 8 weeks after treatment ,sinus healed in group C and D ,but sinus was observed in group A and B ;the gross bone pathologieal scores of group D were significantly better than those of group A and B(P〈0 .05) .Bone defects were repaired completely in group D ,the results of the longest diameter of bone defects in group D was significantly better than those in the other 3 groups (P〈0 .05) .New bone formation was observed in group C and D ,but peri‐osteal reaction and marrow low‐density shadow were observed in group A and B;Norden score in group D was significantly better than those in group A ,B ,and C(P〈0 .05) .HE staining showed that there were a large number of trabecular bone formation and fi‐brosis ,with no obvious signs of infection in group C and D ,but neutrophil accumulation was observed in group A and B ;Smeltzer in group C and D were significantly better than those in group A and B(P〈0 .05) .Bacteriological results showed higher negative rate in group C and D than in groups A and B(P〈0 .05) .Conclusion Cationic liposome‐encapsulated vancomyc and n‐HA/CS compos‐ite scaffold can be a good treatment for infectious bone defects in rabbits ,providing a new strate 3 for the therapy of bone defects in chronic infection .
作者 向柄彦 郭元
出处 《重庆医学》 CAS 北大核心 2015年第8期1032-1034,1038,共4页 Chongqing medicine
基金 遵义市科学技术局联合基金资助项目(2013-1)
关键词 羟基磷灰石/壳聚糖支架 慢性骨髓炎 BMP-2 nano-hydroxyapatite/chitosan glucomannan scaffold cationic liposome vancomyc infected bone defect BM P-2
  • 相关文献

参考文献12

  • 1Huang HK,Chiang CC, Su YP, et al. Rote of autologous hone graft in the surgical treatment of atrophic nonunion midshaft clavicular fractures[J]. Orthopedics, 2012, 35 (2) :e197-201.
  • 2Sharifi D, Khoushkerdar HR, Abedi G, et al. Mechanical propeties of radial bone defects treated with autogenous graft covered with hydroxyapatite in rabbit[J]. Acta Cir Bras,2012,27(3) :256-259.
  • 3Ateschrang A, Ochs BG, Ludemann M, et al. Fibula and tibifusion with cancellous allograft vitalised with autolo- gous bone marrow: first result for infected tibial non-u- nion[J]. Arch Orthc Trauma Surg, 2009,129 (1) : 97-104.
  • 4Ma T, Shang BC, Tang H, et aL Nano-hydroxyapatite/chi- tosan/kojac glucomannan scaffolds loaded with cationic li- posomal vancomycin: preparation, in vitro release and ac- tivity against Staphylococcus aureus biofilms[J]. J Bio- mater Sci Polym Ed,2011,22(12):1669-1681.
  • 5Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis [J]. Am Fam Physician, 2011,84 ( 9 ) : 1027 -1033.
  • 6Shinto Y, Uchida A,Korkusuz F, et al. Calcium hydroxyapa- tire ceramic used as a delivery system for antibiotics[J]. J Bone Jt Surg Br, 1992,74(4) : 600-607.
  • 7赵欣,王德平.纳米羟基磷灰石作为药物载体材料的研究进展[J].材料导报,2010,24(23):116-120. 被引量:7
  • 8Lahiji A, Sohrabi A, Hungerford DS, et al. Chitosan sup- ports the expression of extracellular mat rix proteins in human osteoblasts and chondrocytes[J]. Biomed Mater Res,2000,51(4) :586-595.
  • 9Rey-Rico A, Silva M, Couceiro J, et al. Osteogenic effi- ciency of in situ gelling poloxamine systems with and without bone morphogenetic protein-2[J]. Eur Cell Ma- ter., 2011,21 : 317-340.
  • 10Anusha A, Menon D, Nair S, et al. A molecular receptor targeted, hydroxyapatite nanocrystal based muhimodal contrast agent[J]. Biomaterials, 2013,31 (9) : 2606-2616.

二级参考文献82

共引文献25

同被引文献17

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部